News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
.jpg?sfvrsn=b8be1e0b_2 "breast cancer cell 547x410 (1)")
Targeted immunotherapy could lead to pioneering treatment for breast cancer
A new type of immunotherapy that targets non-cancer cells could help prevent the growth and spread of breast cancer tumours, according to new research from the ICR.
New drug could unlock benefits of immunotherapy for more patients
A new drug could offer a powerful way to sensitise tumours to immunotherapy, a new trial suggests.
Her Majesty The Queen presents cancer researchers with prize at Buckingham Palace
Earlier today, researchers from The Institute of Cancer Research, London, received a prestigious Queen’s Anniversary Prize on behalf of the institute, in recognition of its transformational breast cancer research programme.
'Olive oil' drug shows early promise for some brain cancer patients
A unique drug derived from oleic acid – which naturally occurs in animal and vegetable fats such as olive oil – has shown promise for patients with an advanced form of the most common type of brain cancer, following a study led by The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London.
Researchers develop new approaches to live-track the production of different types of blood cells in mice
Scientists have found a way to monitor in real time how bone marrow stem cells produce the different types of cells in the blood – a process called haematopoiesis.
New study opens the door to learning more about an important driver of breast cancer
Through innovative exploratory work, scientists have identified a new way to study proteins that are involved in the development of the majority of breast cancers.
New AI collaboration could advance precision therapy in breast cancer
A new collaboration between academic and industry researchers could help to improve clinical decision making for cancer patients – including by potentially guiding the use of immunotherapy to breast cancer patients who could benefit from it.
Scientists discover how some advanced breast cancers become resistant to hormone therapy
New research has identified why some advanced oestrogen receptor (ER) positive breast cancers become resistant to hormone therapy, and has identified drugs currently in development that could keep disease stable for longer for these patients.
ICR welcomes appointment of Aviva and Socius for new life-sciences development at The London Cancer Hub
The Institute of Cancer Research has welcomed the appointment of a new partnership to deliver a major redevelopment project at The London Cancer Hub in Sutton.
ICR welcomes recommendation of talazoparib for advanced breast cancer
The Institute of Cancer Research, London, strongly welcomes the news that talazoparib (trade name Talzenna) has been recommended by NICE for the treatment of advanced breast cancer.
We must not rush to implement new genetic screening programmes, experts warn
There is a danger that population genetic screening programmes may be introduced without the necessary scrutiny and rigour that is usually applied when screening programmes are put into effect, experts have warned.
Scientists now able to predict response to radium-223 treatment in prostate cancer bone metastases
Researchers have found a way to predict which patients are likely to respond to radium-223, a standard treatment for advanced prostate cancer that has spread to the bones.
